Biolife Solutions (BLFS) Non-Current Deferred Tax Liability (2021 - 2026)

Biolife Solutions (BLFS) has 6 years of Non-Current Deferred Tax Liability data on file, last reported at $198000.0 in Q1 2026.

• Quarterly Non-Current Deferred Tax Liability rose 52.31% year-over-year to $198000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $198000.0 (up 52.31% YoY) and the FY2025 annual result came in at $189000.0, up 52.42% from the prior year.
• Non-Current Deferred Tax Liability climbed to $198000.0 in Q1 2026 per BLFS's latest filing, from $189000.0 in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $11.2 million in Q4 2022 and bottomed at $100000.0 in Q3 2024.
• The 5-year median for Non-Current Deferred Tax Liability is $193000.0 (2024), against an average of $1.2 million.
• The widest annual swing landed in 2022, when Non-Current Deferred Tax Liability jumped 104.7%; it then sank 98.99% in 2023.
• Tracing BLFS's Non-Current Deferred Tax Liability over 5 years: stood at $11.2 million in 2022, then slumped by 98.99% to $114000.0 in 2023, then advanced by 8.77% to $124000.0 in 2024, then jumped by 52.42% to $189000.0 in 2025, then climbed by 4.76% to $198000.0 in 2026.
• Per Business Quant, the three latest BLFS Non-Current Deferred Tax Liability figures stand at $198000.0 (Q1 2026), $189000.0 (Q4 2025), and $189000.0 (Q3 2025).

Peer Comparison